Koninklijke Philips N.V. (PHG)

Koninklijke Philips (NYSE:PHG) Shares Sold by National Bank of Canada FI

National Bank of Canada FI cut its position in Koninklijke Philips (NYSE:PHG – Free Report) by 89.8% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,339 shares of the technology company’s stock after selling 11,787 shares during the quarter. National Bank of Canada FI’s holdings in Koninklijke Philips were worth $31,000 at the end of the most recent quarter. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Allworth Financial LP boosted its position in shares of Koninklijke Philips by 113.3% during the third quarter. Allworth Financial LP now owns 3,242 shares of the technology company’s stock worth $65,000 after buying an additional 1,722 shares during the period. Spire Wealth Management grew its stake in shares of Koninklijke Philips by 127.2% in the third quarter. Spire Wealth Management now owns 3,446 shares of the technology company’s stock worth $69,000 after purchasing an additional 1,929 shares in the last quarter. Bruce G. Allen Investments LLC acquired a new position in shares of Koninklijke Philips during the fourth quarter valued at $140,000. GAMMA Investing LLC bought a new stake in shares of Koninklijke Philips during the fourth quarter valued at about $146,000. Finally, Contravisory Investment Management Inc. bought a new stake in shares of Koninklijke Philips during the fourth quarter valued at about $200,000. 13.67% of the stock is owned by institutional investors and hedge funds. Koninklijke Philips Price Performance NYSE PHG opened at $27.98 on Monday. Koninklijke Philips has a 1 year low of $17.75 and a 1 year high of $29.44. The business’s fifty day moving average is $22.41 and its two-hundred day moving average is $21.80. The stock has a market capitalization of $25.98 billion, a P/E ratio of -29.15, a P/E/G ratio of 1.21 and a beta of 0.75. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.78 and a current ratio of 1.20. Koninklijke Philips (NYSE:PHG – Get Free Report) last announced its earnings results on Monday, April 29th. The technology company reported $0.28 EPS for the quarter. The business had revenue of $4.49 billion during the quarter. Koninklijke Philips had a positive return on equity of 9.82% and a negative net margin of 4.41%. On average, research analysts forecast that Koninklijke Philips will post 1.53 earnings per share for the current fiscal year. Koninklijke Philips Cuts Dividend The company also recently announced an annual dividend, which was paid on Thursday, May 9th. Stockholders of record on Friday, May 10th were given a $0.9154 dividend. This represents a dividend yield of 3.5%. The ex-dividend date of this dividend was Thursday, May 9th. Koninklijke Philips’s dividend payout ratio (DPR) is currently -95.83%. Analyst Upgrades and Downgrades Several equities analysts have commented on PHG shares. JPMorgan Chase & Co. raised shares of Koninklijke Philips from an “underweight” rating to a “neutral” rating in a research note on Tuesday, April 30th. BNP Paribas raised Koninklijke Philips from an “underperform” rating to a “neutral” rating in a report on Tuesday, May 7th. Sanford C. Bernstein upgraded Koninklijke Philips from a “market perform” rating to an “outperform” rating in a research report on Monday, May 13th. StockNews.com cut Koninklijke Philips from a “buy” rating to a “hold” rating in a research report on Thursday. Finally, UBS Group upgraded Koninklijke Philips from a “sell” rating to a “neutral” rating in a report on Tuesday, April 30th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Koninklijke Philips presently has a consensus rating of “Hold” and an average price target of $19.00. Get Our Latest Stock Report on PHG Koninklijke Philips Profile (Free Report) Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.